Loading clinical trials...
Loading clinical trials...
A Phase 2 Study of Imatinib Therapeutic Drug Monitoring in Gastrointestinal Stromal Tumor
Conditions
Interventions
Imatinib
Locations
1
United States
Markey Cancer Center
Lexington, Kentucky, United States
Start Date
March 26, 2024
Primary Completion Date
December 1, 2027
Completion Date
December 1, 2027
Last Updated
February 17, 2026
NCT06326346
NCT05385549
NCT05440357
NCT06431451
NCT06523582
NCT06507683
Lead Sponsor
Reema A. Patel
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions